Lang & Schwarz
15.11.25 | 13:03
0,028 Euro
-100,00 % -0,028
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,022 | 0,034 | 15.11. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 28.08. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 28.08.2025 | 902 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 28.08.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 28.08.2025.ISIN NameAU000000DHG9 DOMAIN... ► Artikel lesen | |
| 15.08. | Stagezero Life Sciences Ltd (2): Stagezero Life lists on NEX, remains suspended | 3 | Stockwatch | ||
| 14.08. | StageZero Life Sciences Ltd.: StageZero Announces Listing on the NEX Exchange | 1 | TheNewswire | ||
| 14.08. | Stagezero Life Sciences Ltd (2): Stagezero Life Sciences downgraded to NEX | 1 | Stockwatch | ||
| STAGEZERO LIFE SCIENCES Aktie jetzt für 0€ handeln | |||||
| 25.07. | Stagezero Life Sciences Ltd (2): Stagezero to delist from TSX, applies for NEX listing | 2 | Stockwatch | ||
| 25.07. | StageZero Life Sciences Ltd.: StageZero Announces Delisting from the TSX and a Concomitant Application for Listing on the NEX Exchange | 1 | TheNewswire |
6 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CARL ZEISS MEDITEC | 42,680 | -2,16 % | EQS-PVR: Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Carl Zeiss Meditec AG
Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the... ► Artikel lesen | |
| INTUITIVE SURGICAL | 474,35 | +0,29 % | Intuitive Surgical Stock Is Up 31% Since October Lows After Powerful Earnings Turnaround | ||
| BOSTON SCIENTIFIC | 89,40 | +1,13 % | Boston Scientific Up 7% in a Month: How Should You Play the Stock? | ||
| PLUS THERAPEUTICS | 0,510 | -2,54 % | Plus Therapeutics Inc.: Plus Therapeutics Reports Third Quarter Financial Results and Recent Business Highlights | US market introduction of the CNSide® CSF diagnostics platform, with first national coverage agreement with UnitedHealthcare Presented positive RESPECT-LM Ph1 clinical trial results HOUSTON, Oct.... ► Artikel lesen | |
| MOUNTAIN VALLEY MD | 0,005 | +31,58 % | Mountain Valley MD Holdings Inc: Mountain Valley appoints Batchelor as director | ||
| ASENSUS SURGICAL | - | - | GlobalLogic, Asensus ink surgical robotics engineering collab | ||
| EMPOWER CLINICS | - | - | Empower Clinics Inc. - REVOKED, Commission order revoking Exchange Act registration [Section 12(j)] | ||
| LIFEWARD | 0,600 | +15,25 % | Lifeward Ltd. Reports Third Quarter 2025 Financial Results | Record quarter of ReWalk systems placed for Medicare beneficiaries since fee schedule established Ongoing efficiency initiatives drive 16% year-over-year decrease in quarterly cash burn and 27%... ► Artikel lesen | |
| SENSEONICS | 5,450 | -2,07 % | XFRA 6L60: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| EKSO BIONICS | 4,800 | 0,00 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Reports Third Quarter 2025 Financial Results | SAN RAFAEL, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) ("Ekso Bionics" or the "Company"), an industry leader in exoskeleton technology for medical and industrial... ► Artikel lesen | |
| IMUNON | 3,600 | -1,10 % | Imunon, Inc.: IMUNON Reports Third Quarter 2025 Financial Results and Provides Business Update | R&D Day showcased remarkable Investigator optimism, continued strengthening supportive data, and significant progress with Phase 3 OVATION 3 Study in pursuit of first frontline immunotherapy for advanced... ► Artikel lesen | |
| BIOCEPT | 7,200 | 0,00 % | GlaxoSmithKline Bioc: Gewinn im zweiten Quartal bei 5,9 Mio. EGP | ||
| ROCKWELL MEDICAL | 0,785 | -0,38 % | Rockwell Medical: Umsatzrückgang im dritten Quartal lässt Aktie einbrechen | ||
| AVINGER | 0,465 | -22,17 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| MEMPHASYS | 0,002 | 0,00 % | MEMPHASYS LIMITED: Section 708A Cleansing Statement |
STAGEZERO LIFE SCIENCES LTD gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell -100,00 % bei einem Aktienkurs von 0,028 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu STAGEZERO LIFE SCIENCES LTD finden Sie auf Wallstreet Online.